RWS is pleased to announce the new CEO of Corporate Translations

UK
9/1/2016 12:00:01 AM
Sheena succeeds Mary Gawlicki, who along with Ted Gawlicki founded Corporate Translations in 1990 to fulfill the demand for high quality translation services in the life science industry. RWS Group’s medical translation division was integrated into Corporate Translations this year as part of the acquisition. Sheena will lead the RWS Life Science Division into its next phase of global success under the Corporate Translations brand. Andrew Brode, Chairman of RWS Holdings stated, “I am very pleased to have Sheena as a member of the RWS Group and Corporate Translations. I know that Sheena’s long-standing experience in the translation industry and pharmaceutical expertise will be a huge asset to Corporate Translations.” Sheena Dempsey is not a stranger to either the language services or life science industries. For over 20 years, she has accumulated in-depth knowledge of translation services, including extensive experience in operational management, business development, and the specific requirements of the life science sector. She started her career at Siemens before advancing into her executive roles within Lionbridge in both Ireland and the United States. Before joining Corporate Translations, Sheena served as General Manager and Vice President of the Lionbridge Life Sciences Division with global responsibility for developing multilingual solutions for global life sciences sponsors. About RWS: RWS Group is a global leader in language services, employing over 750 staff worldwide. It is a leading provider of intellectual property support services and high level technical translation and localization services for clients in the engineering, electronics, pharmaceutical and life sciences, chemical, legal and financial industries. For further information about RWS Group please contact marketing@rws.com and visit www.rws.com About Corporate Translations Corporate Translations, a proud member of the RWS Group, was founded in 1990 specifically to answer the demand for high quality translations solutions in the pharmaceutical, biotech, and medical device industries. With over 26 years of acquired knowledge in these highly regulated industries, and the recent integration with the RWS Group’s medical translation division, the company has become a recognized expert in managing translation and linguistic validation projects for the world’s top pharmaceutical and biotech companies. For more information about Corporate Translations, please call 860-727-6000 or visit www.corptransinc.com. {fastsocialshare}
Get in touch

About RWS

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.


Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.


Over the past 20 years we’ve been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.


We work with over 80% of the world’s top 100 brands, more than three-quarters of Fortune’s 20 ‘Most Admired Companies’ and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.


Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 


For further information, please visit: www.rws.com.


© 2024 All rights reserved. Information contained herein is deemed confidential and the proprietary information of RWS Group*.
*RWS Group shall mean RWS Holdings plc for and on behalf of its affiliates and subsidiaries.